Work

Nonpeptide αvβ3 Antagonists. 1. Transformation of a Potent, Integrin-Selective αIIbβ3 Antagonist into a Potent αvβ3 Antagonist

Year: 2000

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/jm000133v

Authors: Mark E. Duggan, Le T. Duong, John E. Fisher, Terence G. Hamill, William F. Hoffman, Joel R. Huff, Nathan C. Ihle, Chih-Tai Leu, Rose M. Nagy, James J. Perkins, Sevgi B. Rodan, Gregg Wesolowski, David B. Whitman, Amy E. Zartman, Gideon A. Rodan, George D. Hartman

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Cell Adhesion Molecules Research

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1986083736

FWCI: 2.794

Cites: 20

Cited by: 86

Related to: 10